These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 16619578)
1. Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas--experience and meta-analysis. Van Der Horst-Schrivers AN; Jager PL; Boezen HM; Schouten JP; Kema IP; Links TP Anticancer Res; 2006; 26(2B):1599-604. PubMed ID: 16619578 [TBL] [Abstract][Full Text] [Related]
2. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma? Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651 [TBL] [Abstract][Full Text] [Related]
3. Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas. Berglund AS; Hulthén UL; Manhem P; Thorsson O; Wollmer P; Törnquist C J Intern Med; 2001 Mar; 249(3):247-51. PubMed ID: 11285044 [TBL] [Abstract][Full Text] [Related]
4. 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation. Bhatia KS; Ismail MM; Sahdev A; Rockall AG; Hogarth K; Canizales A; Avril N; Monson JP; Grossman AB; Reznek RH Clin Endocrinol (Oxf); 2008 Aug; 69(2):181-8. PubMed ID: 18394016 [TBL] [Abstract][Full Text] [Related]
5. Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II. De Graaf JS; Dullaart RP; Kok T; Piers DA; Zwierstra RP Eur J Surg; 2000 Apr; 166(4):289-92. PubMed ID: 10817323 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours. Maurea S; Klain M; Caraco C; Ziviello M; Salvatore M Nucl Med Commun; 2002 Oct; 23(10):951-60. PubMed ID: 12352593 [TBL] [Abstract][Full Text] [Related]
7. 123I-metaiodobenzylguanidine scans in phaeochromocytoma diagnosis: current clinical practice and relationship to biochemical screening. Tormey WP; Keeling F; Lee MJ Int J Clin Pract; 1999 Sep; 53(6):428-32. PubMed ID: 10622069 [TBL] [Abstract][Full Text] [Related]
8. 99mTc-HYNIC-TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma. Chen L; Li F; Zhuang H; Jing H; Du Y; Zeng Z J Nucl Med; 2009 Mar; 50(3):397-400. PubMed ID: 19223405 [TBL] [Abstract][Full Text] [Related]
13. [Nuclear medicine diagnosis of pheochromocytoma with metaiodobenzylguanidine]. Pucar D; Marković S Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():20-4. PubMed ID: 12584993 [TBL] [Abstract][Full Text] [Related]
14. Disseminated malignant phaeochromocytoma: localisation with iodine-131-labelled meta-iodobenzylguanidine. Sutton H; Wyeth P; Allen AP; Thurtle OA; Hames TK; Cawley MI; Ackery D Br Med J (Clin Res Ed); 1982 Oct; 285(6349):1153-4. PubMed ID: 6812783 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy. Furuta N; Kiyota H; Yoshigoe F; Hasegawa N; Ohishi Y Int J Urol; 1999 Mar; 6(3):119-24. PubMed ID: 10226821 [TBL] [Abstract][Full Text] [Related]
16. [Noninvasive screening for pheochromocytoma in patients with an incidentally discovered adrenal mass: usefulness of provocative test with metoclopramide and 131I-metaiodobenzylguanidine scintigraphy]. Yokoyama H; Tsuji Y Hinyokika Kiyo; 1999 Oct; 45(10):677-80. PubMed ID: 10586357 [TBL] [Abstract][Full Text] [Related]
17. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters. van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126 [TBL] [Abstract][Full Text] [Related]